Chronic hepatitis C in the Latino population
Tóm tắt
Từ khóa
Tài liệu tham khảo
US Department of Commerce Economics and Statistics Administration, US Census Bureau: The Hispanic population in the United States. March 2002. Available at http://www.census.gov/population/www/hispanic/ho02tabs.html . Accessed June 29, 2004.
US Census Bureau: Census 2000 brief: overview of race and Hispanic origin, 2000. Available at http://www.census.gov/prod/2001pubs/c2kbr01-1.pdf . Accessed May 28, 2008.
Alter MJ, Kruszon-Moran MS, Nainan O, et al.: The prevalence of hepatitis C virus infection in the United Status, 1988 through 1994. N Engl J Med 1999, 341:556–562.
Bonacini M, Groshen MD, Yu MC, et al.: Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol 2001, 96:2438–2441.
Mallet DB, Jeffers L: The natural history of HCV infection in African Americans [editorial]. Am J Gastroenterol 2002, 97:520–522.
Bonds DE, Zaccaro DJ, Karter AJ, et al.: Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2003, 26:1040–1046.
The Health Care Challenge: Acknowledging Disparity, Confronting Discrimination and Ensuring Equality. Volume 1, The Role of Governmental and Private Health Care Programs and Initiatives. Washington, DC: US Commission on Civil Rights; 1999.
Smith CA, Barnett E: Diabetes-related mortality among Mexican Americans, Puerto Ricans and Cuban Americans in the United Status. Rev Panam Salud Publica 2005, 18:381–387.
Rawls RA, Vega KJ: Viral hepatitis in minority America. J Clin Gastroenterol 2005, 39:144–151.
McQuillan GM, Alter MJ, Moyer LA, et al.: A population based serologic study of hepatitis c virus infection in the United States. In Viral Hepatitis and Liver Disease. Edited by Rizzetto M, Purcell RH, Gerin JL, Verme G. Turin, Italy: Edizioni Minerva Medica; 1997:267–270.
Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report, vol 15. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.
Perez CM, Suarez E, Torres EA: Epidemiology of hepatitis C infection and its public health implications in Puerto Rico. PR Health Sci J 2004, 23(Suppl):11–28.
Strader DB: Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis 2005, 41(Suppl 1):S7–S13.
Wise M, Bialek S, Finelli L, et al.: Changing trends in hepatitis C-related mortality in the USA, 1995–2004. Hepatology 2008, 47:1128–1135.
Rodriguez-Torres M, Rios-Bedoya CF, Rodriguez-Orengo J, et al.: Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus and along gender. J Clin Gastroenterol 2006, 40:358–366.
Reyes JC, Colon HM, Robles RR, et al.: Prevalence and correlates of hepatitis C virus infection among street-recruited injection users in San Juan, Puerto Rico. J Urban Health 2006, 83:1105–1113.
Fisher DG, Reynolds GL, Jaffe A, Perez MJ: Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California. J Addict Dis 2006, 25:25–32.
Estrada AL: Health disparities among African Americans and Hispanic drug injectors-HIV, AIDS, hepatitis B virus and hepatitis C virus; a review. AIDS 2005, 19(Suppl 3):S47–S52.
Estrada AL: Drug use and HIV risks among African-American, Mexican-American, and Puerto Rican drug injectors. J Psychoactive Drugs 1998, 30:247–253.
Diaz T, Des Jarlais DC, Vlahov D, et al.: Factors associated with prevalent hepatitis C: differences among young adult injection users in lower and upper Manhattan, New York City. Am J Pub Health 2001, 91:23–30.
Rodriguez-Perez F, Suarez-Perez E, Alvarez-Rohena M, Toro DH: Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico. PR Health Sci J 2004, 23(2 Suppl):49–56.
Cheung RC, Currie S, Shen H, et al.; VA HCV-001 Study Group: Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. Am J Gastoenterol 2005, 100:2186–2193.
Bachus LI, Boothroyd D, Deyton LR: HIV, hepatitis C virus co-infection in vulnerable populations. AIDS 2005, 19(Suppl 3):S13–S19.
Lepe R, Layden-Almer JE, Layden TJ, Cotler S: Ethnic differences in the presentation of chronic hepatitis. C J Viral Hepat 2006, 13:116–120.
Verma S, Bonacini M, Govindarajan S, et al.: More advanced hepatic fibrosis in Hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol 2006, 101:1817–1823.
Crosse K, Omeadi OG, Anana FA, et al.: Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol 2004, 2:463–468.
Di Bisceglie AM, Lyra AC, Reddy RK, et al.: Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003, 98:2060–2063.
Bhattacharya R, Shuhart MC: Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 2003, 36:242–252.
Lee DJ, Markides KS, Ray LA: Epidemiology of self reported past heavy drinking in Hispanic adults. Ethn Health 1997, 2:77–88.
Drugs and Alcohol in Puerto Rico. Puerto Rico Substance Abuse Program. Hato Rey, PR: Mental Health and Anti-addiction Services Administration; 2003.
Adinolfi L, Gambardella M, Andreana A, et al.: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001, 33:1358–1364.
Castera L, Hezode C, Roudot-Thoraval F, et al.: Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003, 52:288–292.
Vidali M, Tripodi MF, Ivaldi A, et al.: Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008, 48:399–406.
Weston SR, Leyden W, Murphy R, et al.: Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005, 41:372–379.
Caballero AE: Diabetes in the Hispanic or Latino population: genes, environment, culture, and more. Curr Diab Rep 2005, 5:217–225.
Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28:2745–2749.
Haffner SM, D’Agostino R, Saad MF, et al.: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996, 45:742–748.
Langefeld CD, Wagenknecht LE, Rotter JI, et al.: Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 2004, 53:1170–1174.
Kirby JB, Taliaferro G, Zuvekas SH: Explaining racial and ethnic disparities in health care. Med Care 2006, 44(5 Suppl):I64–I72.
Butt AA, Justice AC, Skanderson M, et al.: Rate and predictors of treatment prescription for hepatitis C. Gut 2007, 56:385–389.
Trooskin SB, Navarro VJ, Winn RJ, et al.: Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity. World J Gastroenterol 2007, 13:1074–1078.
Fried MW, Shiffman ML, Reddy KR, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975–982.
Hepburn MJ, Hepburn LM, Cantu NS, et al.: Differences in treatment outcome for hepatitis C among ethnic groups. Am J Med 2004, 117:163–168.
Brown RS, Jacobson IM, Afdhal N, et al.: Differences in treatment outcome to antiviral therapy based on genotype and viral load in hepatitis C genotypes 2 and 3 in the WINR trial. Presented at Digestive Disease Week 2006. Los Angeles, CA; May 20–25, 2006.
Rodriguez-Torres M, Jeffers LJ, Sheikh MY, et al.; on behalf of the LATINO. Virologic responses to peginterferon alfa-2a/ribavirin in treatment-naïve Latino vs. non-Latino Caucasians infected with HCV genotype 1: the Latino Study. Presented at the 42nd Annual Meeting of the European Association for the Study of the Liver. Milan, Italy; April 23–27, 2008.
Conjeevaram HS, Kleiner DE, Everhart JE, et al.: Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 2007, 45:80–87.
Gupta K, Romney D, Briggs M, Benker K: Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at innercity hospitals. J Community Health 2007, 32:221–230.
Schackman BR, Teixeira PA, Beeder AB: Offers of hepatitis C care do not lead to treatment. J Urban Health 2007, 84:455–458.